Skip to content

Drug interactions

Ipratropium-salbutamol + Pasireotide

Severity: Moderate

Ipratropium-salbutamol and Pasireotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pasireotide can prolong the QT interval and cause bradycardia. Salbutamol may add to arrhythmia risk through tachycardia and hypokalemia, mainly at high doses.

What this interaction means in plain words

Ipratropium-salbutamol and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ipratropium-salbutamol belongs to Respiratory; Pasireotide belongs to Endocrine.

Evidence level: Low

Why it happens

Additive QT prolongation, with salbutamol-induced hypokalemia as a contributing factor.

What to do

Check ECG and correct potassium and magnesium abnormalities while on pasireotide. Avoid frequent high-dose salbutamol where possible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ipratropium-salbutamol and Pasireotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ipratropium-salbutamol with Pasireotide?

MediHelp rates the interaction as moderate. Ipratropium-salbutamol and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pasireotide can prolong the QT interval and cause bradycardia. Salbutamol may add to arrhythmia risk through tachycardia and hypokalemia, mainly at high doses.

How serious is the interaction between Ipratropium-salbutamol and Pasireotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check ECG and correct potassium and magnesium abnormalities while on pasireotide. Avoid frequent high-dose salbutamol where possible.

What other medicines interact with Ipratropium-salbutamol?

MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in